SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Perry who wrote (3042)5/29/1998 1:05:00 PM
From: Anthony Wong  Read Replies (1) | Respond to of 9523
 
Perry and all, there's a Bloomberg article in the Pharma News thread that talks about PFE being a good candidate for acquiring Monsanto. This bit of news may also affect the price of PFE.



To: Perry who wrote (3042)5/29/1998 3:46:00 PM
From: BigKNY3  Read Replies (1) | Respond to of 9523
 
ICOS was first mentioned on this Board on 3/13/98 when it was 13 3/8. It also includes an abstract on Vasomax. www3.techstocks.com

"-This week's stock to watch: ICOS: Only Pharma with another PDE-V inhibitor in Phase II studies.( Approval of Viagra should have a positive impact.)"

Vasomax has not even been submitted to the FDA yet. Efficacy of 30-40% in ED is way below Viagra. May try to compete via price.

BigKNY3


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News